In recent years, renal biopsy technology is the rapid spread of the
pathological diagnosis of kidney disease, in particular, considerable progress
in the diagnosis of glomerular disease. But indeed there are some urgent
attention and improvement. The first clear pathological diagnosis of renal
biopsy light microscopy, immunopathologic, and electron microscopy diagnosis.
Around as soon as possible to create conditions for active collaboration, so
that with the necessary conditions of the renal biopsy diagnosis. Some units
(including the low quality of some of the conditions of good general hospital)
producer, such as optical mirror slice is too thick (should be 2 to 3μm), the
lack of special stains (PASM, PAS, Masson, and other necessary special stains,
etc.); The renal biopsy specimen of the small number of units without
immunofluorescence or immunohistochemistry, namely the pathology report; quite a
number of unit power microscope, ultrastructural examination is not into the
routine examination in the pathology. Some units lack pathologist familiar with
the kidney pathology or kidney disease have a more extensive knowledge of
pathology, general practitioners, or both, the lack of close cooperation and
discussion. Above, greatly affect the correct pathological diagnosis of renal
biopsy, should pay more attention and timely improvement of the Journal of
Nephrology. Second edition, Beijing: People's Health Publishing House, 1996.424
~ 435]. We focus on the pathological diagnosis of primary glomerular diseases in
China could easily cause confusion and deserves our attention some of the issues
the child proposed for the reference and correction of their fellow
1, minimal change nephropathy (MCD)
Necessary to conscientiously observe the ultrastructural changes of the
electron microscope, diffuse foot process fusion and glomerular generally
electron dense, even in the vice mesangial small electron dense as an important
pathological features of MCD. Immunofluorescence specimens unsatisfactory or no
glomerular rely only on observed by light microscopy to be confused with mild
lesions with mild mesangial proliferative glomerulonephritis and early
membranous nephropathy, can even be mistaken for the normal glomerulus. In the
diagnosis of insufficient evidence, temporarily known as the glomerular minor
lesion may be more appropriate.
Despite international IgM nephropathy is still controversial or different
views, a massive proteinuria or nephrotic syndrome, renal pathology
immunofluorescence showed mesangial area clear of IgM deposition under the light
microscope can be mild mesangial proliferative , although electron microscopy of
glomerular epithelial cell foot suddenly wide range of integration, we should
still diagnosis of mesangial IgM nephropathy, and should be further follow-up.
Middle-aged patients with minimal change disease, erythrocyte sedimentation rate
abnormal increase in the fast should be carefully excluded the possibility of
malignancy.
2, focal segmental glomerulosclerosis (FSGS)
Note first of all distinguish the glomerular lesions of focal segmental
glomerular sclerosis with focal segmental sclerosis, which may occur in a
variety of glomerular diseases, while the former is a specific renal ball
disease. In recent years, many scholars abroad to promote the classic FSGS,
collapsing glomerulopathy and state-of-the-art glomerular injury in two subtypes
should be increased. Collapsing glomerulopathy (collapsing glomerulopathy, CG)
has its own pathology and clinical particularity. CG of the pathological
features of the glomerular capillary loops showed the limitations of segmental
collapse. Sometimes as a global collapse, GBM performance wrinkled, folded,
glomerular epithelial cells were significantly swelling, hypertrophy and
hyperplasia of epithelial cells was more nuclear, cytoplasm containing a
transparent kind of DROP or vacuolization, the vast The majority of patients
were nephrotic syndrome, urinary protein> 10g/24h, the efficacy of hormonal
and cytotoxic drugs, the majority of patients with renal function deterioration.
Therefore, CG is considered to be the poor prognosis of a special kind of
pathological changes of FSGS. According to reports, CG is a high incidence among
blacks, CG about 5% to 15% of [the Kidney Int FSGS in 1994,45:1416 1424].
State-of-the-art glomerular damage (glomerular tip lesion) means the glomerular
sclerosis uttermost parts in the urine of the vascular pole, and is generally
believed that this kind of pathological changes in patients on hormonal and
cytotoxic treatment response is better, FSGS in prognosis relatively good kind
of pathological changes.
Pathological type of FSGS in elderly patients with nephrotic syndrome should
be excluded from renal amyloidosis, diabetic nephropathy, light chain
nephropathy and multiple myeloma nephropathy may be, can be combined with
clinical and Congo red staining, the specific antibody immune staining (such as
anti-Kappa or lambda light chain antibodies) and ultrastructure of careful
observation to be identified.
Several domestic Kidney Disease Research Center of primary nephrotic
syndrome, renal biopsy data analysis showed that the FSGS proportion of large
difference can be> 15% or <5%. This variation causes speculation and
pathologist to master standard, diagnostic thinking, especially glomerular
diseases associated with glomerular lesions of focal segmental sclerosis
appropriately diagnosed, yet to be domestic kidney disease academic as soon as
possible unified.
3, membranous nephropathy
Atypical membranous nephropathy (ie, addition to the pathology of membranous
nephropathy itself, there are varying degrees of mesangial cells and mesangial
matrix, immunopathologic, and electron microscopy with membranous nephropathy),
consideration should be given to the type Ⅴ lupus nephritis or hepatitis B virus
associated glomerulonephritis secondary to glomerular diseases may, clinical,
serological, serum HBV antigen detection and kidney slices by
immunohistochemical detection of antigen (such as HBV antigen) further
confirmed.
In the light microscope, the early membrane lesion (Ⅰ of membranous
nephropathy) often lack a clear pathological changes, such as the lack of
immunofluorescence specimens glomerular immunofluorescence specimens is not
ideal, necessary for careful observation in the electron microscope the GBM
epithelial cell side with or without electronic dense material (ED) and (or)
using paraffin section immunohistochemistry to observe the distribution and the
formation of IgG, C3, should not solely on the basis of the results of light
microscopy misdiagnosed as mild disease, minimal change or mild mesangial
proliferative nephritis.
Pathologically confirm the diagnosis in patients with membranous nephropathy,
particularly ESR abnormal increase in the elderly patients should be the
detailed examination to exclude malignancy (such as lymphoma, lung cancer),
renal amyloidosis may.
4, mesangial proliferative glomerulonephritis (MsPGN)
China with a high incidence can have a variety of different clinical
manifestations, response to treatment and prognosis of variation is great.
Generally based on the characteristics of immunofluorescence into IgA and
non-IgA mesangial proliferative glomerulonephritis, the former
immunofluorescence IgA-based, the latter of IgG or IgM-dominated deposition in
the mesangial area. Light microscopy should be based on the mesangial cells and
stromal hyperplasia of the degree of glomerular capillary loops open and
pressure, divided into light, medium and heavy three. Different response to
treatment and prognosis.
For MsPGN patients should be combined with the clinical and the laboratory
examination, pay attention to the differentiated kidney damage caused by
systemic diseases and allergic purpura, systemic lupus erythematosus and
cirrhosis. The primary MsPGN patients should also consider whether the
dissipation of the capillary proliferative glomerulonephritis (acute infection
glomerulonephritis) of.
Patients with hematuria, renal pathology immunofluorescence negative, thin
light microscope, normal or showed mild mesangial proliferative lesions should
be carefully investigating the family history of the hematuria, and careful
observation of the GBM ultrastructural changes and the relevant checks to
exclude basement membrane nephropathy or the possibility of early Alport
syndrome.
5, the capillary proliferative glomerulonephritis
Should be noted that the difference of the capillary proliferative
glomerulonephritis dissipation of mesangial proliferative glomerulonephritis,
electron microscopy former GBM epithelial cells of the "Hump" to dissipate
moth-eaten legacy lucent zone to assist in identifying; In addition, the
combination of acute nephritic syndrome history, C3 dynamic change, ASO titer,
and infection and the onset interval to help both identify all help.
Capillary proliferative glomerulonephritis characteristic pathological types
of glomerulonephritis in the acute infection, many cases of domestic IgA
nephropathy light microscope, the pathological changes in the endothelial cells,
mesangial cell proliferation, capillary loops compression for outstanding
performance, it should be based on immune fluorescence and clinical
manifestations (serum IgA level, ASO, C3, infection and onset interval, etc.) to
distinguish between the two.
Ⅳ lupus nephritis can be expressed endocapillary proliferative nephritis
pathological changes, it should be combined with antinuclear antibodies and
other immunological tests and other clinical manifestations of carefully
identified.
6, membrane proliferative glomerulonephritis (MPGN)
Idiopathic nephritis should be carefully observed in the electron microscope,
the distribution of parts according to the electron-dense material, and in
combination with other pathological features (if double-track sign,
immunofluorescence features) distinguish Ⅰ, Ⅱ, Ⅲ type.
Western developed countries MPGN type Ⅰ the MPGN incidence rate decreased
significantly, and may improve related health conditions, air pollution. In the
pathological type accounting for primary nephrotic syndrome in 10% to 15% of the
vast majority of type MPGN Ⅰ.
Pathological manifestations of MPGN patients, in conjunction with clinical
and laboratory tests (including kidney immune pathology examination), carefully
exclude the hepatitis B virus associated glomerulonephritis, hepatitis C virus
associated glomerulonephritis, cryoglobulinemia kidney damage and lupus
nephritis possible.
7, crescentic nephritis
In recent years, anti-neutrophil cytoplasmic antibodies (ANCA) testing is
widely used in clinical practice, crescentic nephritis is traditionally divided
into Ⅰ, Ⅱ, Ⅲ type of classification is under attack, most scholars recently
advocated basis for ANCA and anti- glomerular basement membrane (GBM), results
in greater detail is divided into five types [of The kidney 5th ed. Philadephia:
WBS Saunders Company, 1996. 1 392 ~ 1 432].
Based solely on light microscopic examination to confirm the diagnosis of
crescentic glomerulonephritis is not enough, should be combined with
immunofluorescence, serum anti-GBM antibody and ANCA detection and clinical
manifestations (such as hemoptysis, etc.), carefully identify the crescentic
glomerulonephritis of what kind of type, take reasonable treatment, the
prognosis is crucial. Anti-GBM antibody-positive rapidly progressive
glomerulonephritis (RPGN) I light microscope and electron microscope in the
early lesions often can be observed in a clear and serious GBM rupture,
degeneration; ANCA positive RPGN Ⅲ type (Many scholars believe that the small
blood vessels inflammation of the kidneys localized) in most patients with renal
biopsy specimens can be observed more diffusely distributed segmental capillary
loops fibrinoid necrosis, and a small number of patients (20%) can be found in
necrotizing renal arteritis. Show the different types of crescentic nephritis
their pathological features. Must be pointed out that the RPGN I type renal
biopsy specimen by immunofluorescence examination, the early shows IgG and C3
along the GBM was smooth lines, kind of typical distribution, but the course of
the disease later, because of the GBM rupture, degeneration and / or anti-GBM
and GBM combine to form immune complexes and which led to the generation of the
second antibody, some patients with IgG and C3 can be presented to the granular
distribution along the GBM, etc., often misdiagnosed as immune complex-mediated
type II RPGN. Type III RPGN kidney specimens by immunofluorescence negative or
only weak IgM and / or C3 deposition. We believe that the RPGN patients with
conventional anti-GBM antibodies and ANCA testing, carefully observe the
pathological changes and clinical data for the right to distinguish between
different types of RPGN is very important.
8, sclerosis of glomerular nephritis and sclerosing glomerulonephritis
Various types of glomerulonephritis sustainable development, so that part of
the (more than 50%) completely destroyed leading to global sclerosis.
Glomerulus, the surviving structure can still identify the type of the original
glomerular pathology may be said of a certain type of glomerulonephritis caused
by proliferative sclerosing glomerulonephritis. If the structure of the
remaining glomerulus has been unable to identify the type of primary glomerular
lesions, can be collectively referred to as proliferative sclerosing
glomerulonephritis. More than 70% of the total number of glomerular glomerular
sclerosis, can be called sclerosing glomerulonephritis. Glomerulosclerosis by
other systemic diseases such as diabetes, amyloidosis, hypertension, small
vessel vasculitis, systemic lupus erythematosus and other systemic diseases
caused should be noted that the identification of renal pathology and clinical
Changsha: Hunan Science and Technology Press, 1993.41 53.]
In summary, the diagnosis of primary glomerular disease should be closely
combined with clinical and related inspections, serious rule out the possibility
of systemic or genetic disease, response to light microscopy, immunofluorescence
and electron microscopy Ultrastructural pathological changes, careful
observation and comprehensive analysis in order to obtain a correct diagnosis of
pathological types of primary glomerular diseases.
FSGS Patients Give Immunotherapy the Golden Opinions
Here is a great herbal doctor who cured me of Hepatitis B. his name is Dr. Imoloa. I suffered Hepatitis B for 11 years, I was very weak with pains all over my body my stomach was swollen and I could hardly eat. And one day my brother came with a herbal medicine from doctor Imoloa and asked me to drink and I drank hence there was no hope, and behold after 2 week of taking the medicine, I started feeling relief, my swollen stomach started shrinking down and the pains was gone. I became normal after the completion of the medication, I went to the hospital and I was tested negative which means I’m cured. He can also cure the following diseases with his herbal medicine...lupus, hay fever, dry cough, diabetics hepatitis A.B.C, mouth ulcer, mouth cancer, diarrhoea, liver/kidney inflammatory, eye cancer, skin cancer disease, malaria, chronic kidney disease, food poisoning, parkinson disease, bowel cancer, bone cancer, brain tumours, asthma, arthritis, epilepsy, cystic fibrosis, alzhemer's disease, acute myeloid leukaemia, acute pancreatitis, Addison's disease back acne, breast cancer, allergic bronchitis, Celia disease, bulimia, congenital heart disease, cirrhosis, constipation, fungal nail infection, fabromyalgia, (love spell) and many more. he is a great herbalist man. Contact him on email; drimolaherbalmademedicine@gmail.com. You can also reach him on whatssap- +2347081986098.
ReplyDeleteReply
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
ReplyDeleteliver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.